Core Laboratories N.V. is a Netherlands limited liability company. We were
established in 1936 and are one of the world's leading providers of proprietary
and patented reservoir description and production enhancement services and
products to the oil and gas industry, primarily through client relationships
with many of the world's major, national and independent oil companies.

We operate our business in two segments. These complementary operating segments
provide different services and products and utilize different technologies for
evaluating and improving reservoir performance and increasing oil and gas
recovery from new and existing fields:


Reservoir Description: Encompasses the characterization of petroleum reservoir
rock and reservoir fluids samples to increase production and improve recovery of
crude oil and natural gas from our clients' reservoirs. We provide
laboratory-based analytical and field services to characterize properties of
crude oil and crude oil-derived products to the oil and gas industry. We also
provide proprietary and joint industry studies based on these types of analyses
and manufacture associated laboratory equipment. In addition, we provide
reservoir description capabilities that support various activities associated
with energy transition projects, including services that support carbon capture,
utilization and storage, hydrogen storage, geothermal projects, and the
evaluation and appraisal of mining activities around lithium and other elements
necessary for energy storage.


Production Enhancement: Includes services and manufactured products associated
with reservoir well completions, perforations, stimulations, production and well
abandonment. We provide integrated diagnostic services to evaluate and monitor
the effectiveness of well completions and to develop solutions aimed at
increasing the effectiveness of enhanced oil recovery projects.

General Overview



We provide services as well as design and produce products which enable our
clients to evaluate and improve reservoir performance and increase oil and gas
recovery from new and existing fields. These services and products are generally
in higher demand when our clients are investing capital in their field
development programs that are designed to increase productivity from existing
fields or when exploring for appraising and developing new fields. Our clients'
investment in capital expenditure programs tends to correlate over the longer
term to oil and natural gas commodity prices. During periods of higher, stable
prices, our clients generally invest more in capital expenditures and, during
periods of lower or volatile commodity prices, they tend to invest less.
Consequently, the level of capital expenditures by our clients impacts the
demand for our services and products.

The following table summarizes the annual average and year-end worldwide and
U.S. rig counts for the years ended December 31, 2022, 2021 and 2020, as well as
the annual average and year-end spot price of a barrel of WTI crude, Europe
Brent crude and an MMBtu of natural gas:

                                                          2022                  2021              2020
Baker Hughes Worldwide Average Rig Count (1)                    1,747              1,362            1,351
Baker Hughes U.S. Average Rig Count (1)                           721                475              436
Baker Hughes U.S. Land-based Average Rig
Count (1)                                                         706                461              420
Baker Hughes Worldwide Year-End Rig Count (2)                   1,835              1,563            1,095
Baker Hughes U.S. Year-End Rig Count (2)                          780                579              339
Baker Hughes U.S. Land-based Year-End Rig
Count (2)                                                         763                565              324
Average Crude Oil Price per Barrel WTI (3)         $            94.90       $      68.14       $    39.17
Average Crude Oil Price per Barrel Brent (4)       $           100.93       $      70.86       $    41.96
Average Natural Gas Price per MMBtu (5)            $             6.45       $       3.89       $     2.02
Year-end Crude Oil Price per Barrel WTI (3)        $            80.16       $      75.33       $    48.35
Year-end Crude Oil Price per Barrel Brent (4)      $            82.82       $      77.24       $    51.22
Year-end Natural Gas Price per MMBtu (5)           $             3.52       $       3.82       $     2.36
(1) Twelve month average rig count as reported by Baker Hughes - Worldwide Rig Count.
(2) Year-end rig count as reported by Baker Hughes - Worldwide Rig Count.
(3) Average daily and year-end West Texas Intermediate ("WTI") crude spot price as reported by the U.S.
Energy Information Administration ("EIA").
(4) Average daily and year-end Europe Brent crude spot price as reported by the EIA.
(5) Average daily and year-end Henry Hub natural gas spot price as reported by the EIA.




                                       24

--------------------------------------------------------------------------------


The events associated with the COVID-19 pandemic that began in 2020 continued in
2021 and began to subside in 2022. Certain international countries continued
mandated shut-downs, home sheltering and social distancing policies that
initially caused uncertainty in the demand for crude oil and associated
products; however demand for these products has recovered more quickly than
global production causing crude-oil commodity prices to increase significantly.
Although U.S. land drilling and completion activities continued to show
improvement during 2021 and strengthened in 2022, activity still remains well
below pre-pandemic levels. Additionally, in the first half of 2022,
international activity continued to be adversely impacted by increasing
infection rates associated with new variant strains of the COVID-19 virus during
2021 and 2022, which has continued to cause business disruptions associated with
government mandated shut-downs, travel restrictions, quarantine protocols and
worksite closures in various international regions. These disruptions started to
ease during second half of 2022.

The prices for both WTI and Brent crude oil decreased significantly at the end
of the first quarter of 2020 and remained low throughout most of 2020. Crude-oil
prices subsequently recovered in 2021 with more significant improvement during
the second half of 2021, and the average price was 71% higher than in 2020, as
growth in production was not keeping pace with the resurgence in consumer
demand. The geopolitical conflict between Russia and Ukraine that erupted in
February 2022, has also resulted in disruptions to traditional supply chains
associated with the movement of crude oil, primarily reducing the level of crude
oil sourced from Russia and being imported into various European ports. These
disruptions have caused another sharp increase in the price of crude oil
throughout the majority of 2022, which resulted in the average price being 41%
higher in 2022 compared to 2021. However, in order to reduce oil prices in 2022,
the United States government also released approximately 1 million barrels of
oil per day from its Strategic Petroleum Reserve ("SPR") during most of 2022,
reducing the United States SPR by approximately 220 million barrels.

In general, activities associated with the exploration of oil and gas in the
U.S. onshore market are more sensitive to changes in the crude-oil commodity
prices, as opposed to larger international and offshore projects which take
multiple years to plan and develop, and once announced and started, will
continue through completion, despite changes in the current price of crude oil.
Activity levels in the U.S. onshore market also responded immediately to the
changes in demand, decreasing significantly to historically low levels in 2020,
which bottomed in the summer of 2020, and subsequently began to recover in the
second half of 2020 and into 2021. However, the growth in production has not
kept pace with the resurgence in demand for energy produced from oil and gas,
coupled with an adverse impact from global supply-chain challenges especially
during the latter part of 2021. Crude-oil commodity prices remain volatile and
continued to increase significantly during 2022, as a result of the
Russia-Ukraine geopolitical conflict and the additional uncertainty in supply of
crude oil and natural gas. The activities associated with the production of oil
and gas increased throughout 2022; however, growth moderated due to limitations
in personnel, equipment, supply chain disruptions, as well as the allocation of
capital resources by oil and gas producing companies.

Information published by the EIA, shows that the inventory of wells drilled but
uncompleted (a "DUC" well) in the United States, was 7,737 as of December 31,
2020, and declined to 5,099 and 4,577 at end of 2021 and 2022, respectively.
This data indicates that during the period of higher activity prior to 2020,
operators were drilling wells but not completing them as the DUC inventory grew.
The activity levels began to decline in 2020 as operators began to drill fewer
new wells and were completing some of the wells that had been previously
drilled. As drilling and completing activity levels began to recovery in the
second half of 2021 and 2022, the number of wells completed continued to outpace
the number of new wells drilled during these periods.

In the U.S., the average land-based rig count increased approximately 10% from
2020 to 2021 as drilling activity began to recover from the disruptions caused
by the COVID-19 pandemic. The growth in U.S. land drilling activity continued
and the pace accelerated in 2022, as the U.S. average land-based rig count
increased approximately 53% in 2022. Demand for product sales increased in
tandem with the increase in the rig count and the increase in drilling and
completing well activity. Demand for services has also improved and partially
recovered but at a slower pace than demand for completion products. Activities
on development projects and producing fields in U.S. unconventional reservoirs
showed an increase when the commodity price strengthened, and demand for both
services and product sales to this market responded accordingly.

Outside of the U.S., activities associated with the exploration for, and
production of, oil also showed a decline in 2021 primarily due to the prolonged
impact from the global pandemic as reflected by a decrease of 3% in the average
number of active rigs outside the United States. In 2022, activity in most
international regions increased which is reflected by an increase of 16% in the
average number of active rigs outside the U.S. Long-term international and
offshore projects which are commonly announced through Final Investment
Decisions and subsequently initiated are not as susceptible or at-risk to delay
or suspension due to short-term volatility in crude-oil commodity prices.

In response to market conditions in 2020, the Company implemented cost reduction
initiatives, which included (i) corporate and operating cost reductions; (ii)
reduction in annual capital expenditures, and (iii) eliminating all
non-essential costs. The corporate and operating cost reductions included
reductions in workforce and reduction of senior executive and employee

                                       25
--------------------------------------------------------------------------------


compensation. These initiatives continued in 2021. Following increased activity
levels during the second half of 2021, the Company progressively reinstated
certain employee costs, and in January 2022, temporary salary reduction measures
were fully reinstated. Certain employee benefit plans have been partially
reinstated beginning April 2022, and the Company will continue to evaluate the
reinstatement of those benefits as the market for oilfield service companies
continues to more fully recover and stabilize. The Company has also maintained
its annual capital expenditures between $10 million and $13.5 million during the
years 2020, 2021 and 2022, which is significantly reduced from average annual
capital expenditures in years prior to 2020.

Results of Operations

Operating Results for the Year Ended December 31, 2022 Compared to the Years Ended December 31, 2021 and 2020



We evaluate our operating results by analyzing revenue, operating income and
operating income margin (defined as operating income divided by total revenue).
Since we have a relatively fixed cost structure, decreases in revenue generally
translate into lower operating income results. Results for the years ended
December 31, 2022, 2021 and 2020 are summarized in the following chart. The year
ended December 31, 2020, operating loss includes approximately $132.6 million of
charges associated with impairment of goodwill, intangible assets and inventory
write-downs.

                     [[Image Removed: img195230833_4.jpg]]



                                       26

--------------------------------------------------------------------------------

Results of operations as a percentage of applicable revenue for the years ended
December 31, 2022, 2021 and 2020 are as follows (in thousands, except for per
share information):

                                                                                                                                                       2022 / 2021        2021 / 2020
                                               2022                                    2021                                    2020                               % Change
REVENUE:
Services                          $   346,974               70.8 %        $   344,342               73.2 %        $   376,421               77.3 %              0.8 %             (8.5 )%
Product sales                         142,761               29.2 %            125,910               26.8 %            110,846               22.7 %             13.4 %             13.6 %
Total revenue                         489,735              100.0 %            470,252              100.0 %            487,267              100.0 %              4.1 %             (3.5 )%
OPERATING EXPENSES:
Cost of services* (1)                 274,297               79.1 %            267,641               77.7 %            279,281               74.2 %              2.5 %             (4.2 )%
Cost of product sales* (1)            119,358               83.6 %            100,255               79.6 %             95,486               86.1 %             19.1 %              5.0 %
Total cost of services and
product
  sales                               393,655               80.4 %            367,896               78.2 %            374,767               76.9 %              7.0 %             (1.8 )%
General and administrative
expense (1)                            38,117                7.8 %             44,173                9.4 %             34,033                7.0 %            (13.7 )%            29.8 %
Depreciation and amortization          17,161                3.5 %             18,516                3.9 %             20,867                4.3 %             (7.3 )%           (11.3 )%
Impairments and other charges               -                  -                    -                  -              122,204               25.1 %               NM                 NM
Inventory write-down                        -                  -                    -                  -               10,375                2.1 %               NM                 NM
Other (income) expense, net              (722 )             (0.1 )%            (5,595 )             (1.2 )%             1,826                0.4 %               NM                 NM
OPERATING INCOME (LOSS)                41,524                8.5 %             45,262                9.6 %            (76,805 )            (15.8 )%            (8.3 )%              NM
Interest expense                       11,570                2.4 %              9,152                1.9 %             14,372                2.9 %             26.4 %            (36.3 )%
Income (loss) from continuing
operations
   before income taxes                 29,954                6.1 %             36,110                7.7 %            (91,177 )            (18.7 )%           (17.0 )%              NM
Income tax expense (benefit)           10,296                2.1 %             15,891                3.4 %              5,896                1.2 %            (35.2 )%           169.5 %
Income (loss) from continuing
operations                             19,658                4.0 %             20,219                4.3 %            (97,073 )            (19.9 )%            (2.8 )%              NM
Income (loss) from
discontinued
   operations, net of income
taxes                                       -                  -                    -                  -                 (424 )             (0.1 )%              NM                 NM
Net income (loss)                      19,658                4.0 %             20,219                4.3 %            (97,497 )            (20.0 )%            (2.8 )%              NM
Net income (loss)
attributable to
   non-controlling interest               205                  -                  492                0.1 %                140                  -                 NM                 NM
Net income (loss)
attributable to
   Core Laboratories N.V.         $    19,453                4.0 %        $    19,727                4.2 %        $   (97,637 )            (20.0 )%            (1.4 )%              NM

Diluted earnings (loss) per
share
from continuing operations        $      0.42                             $      0.43                             $     (2.18 )                                (2.3 )%              NM

Diluted earnings (loss) per
share
  attributable to Core
Laboratories N.V.                 $      0.42                             $      0.42                             $     (2.20 )                                 0.0 %               NM

Diluted weighted average
common
  shares outstanding                   46,813                                  46,690                                  44,477
Other Data:
Current ratio (2)                      2.05:1                                  2.08:1                                  1.85:1
Debt to EBITDA ratio (3)               2.68:1                                  2.70:1                                      NM
Debt to Adjusted EBITDA ratio
(4)                                    2.29:1                                  2.08:1                                  2.82:1

* Percentage based on applicable revenue rather than total revenue.
"NM" means not meaningful.
(1) Excludes depreciation.
(2) Current ratio is calculated as follows: current assets divided by current liabilities.
(3) Debt to EBITDA ratio is calculated as follows: debt less cash divided by the sum of consolidated net income plus interest, taxes, depreciation, and amortization.
(4) Debt to Adjusted EBITDA ratio is calculated as follows: debt less cash divided by the sum of consolidated net income plus interest, taxes, depreciation, amortization, severance,
and certain non-cash adjustments.


Service Revenue



Service revenue is primarily tied to activities associated with the exploration,
production, movement and refinement of oil, gas and derived products outside the
U.S. Service revenue for the year ended December 31, 2022 of $347.0 million was
relatively flat compared to 2021. Disruptions resulting from the COVID-19
pandemic started to ease, and demand for crude oil progressively increased
during 2022, however, the growth was offset by the disruptions to the movement
and trading patterns of crude oil exported out of Russia and into various
European ports caused by the Russia-Ukraine geopolitical conflict. New
logistical patterns associated with the supply lines of crude oil and derived
products, coming out of Russia and primarily coming into Europe, continue to
realign. Additionally, as over 70% of service revenue is generated from
international markets, though our customer contracts substantially are
denominated in U.S. Dollars, there are certain customer contracts denominated in
foreign currencies. Therefore, the devaluation of most major currencies against
the U.S. Dollar, primarily the Euro and British Pound, adversely impacted the
growth of service revenue during the year ended December 31, 2022. Service
revenue

                                       27
--------------------------------------------------------------------------------


for the year ended December 31, 2021 was $344.3 million down from $376.4 million
in 2020, primarily due to the impact of the COVID-19 pandemic beginning in March
2020 and continuing throughout most of 2021, resulting in delays of exploration
and production projects in both the offshore and international markets, as well
as the U.S. market.

We continue to focus on large-scale core analyses and reservoir fluids
characterization studies in the Eagle Ford, the Permian Basin and the Gulf of
Mexico, along with Guyana, Surinam, Malaysia and other international locations
such as offshore South America, Australia, and the Middle East, including Kuwait
and the United Arab Emirates. Analysis of crude oil and crude oil-derived
products also occurs in every major producing region of the world.

Product Sales Revenue



Product sales revenue, which is equally tied to the completion of onshore wells
in the U.S. and international activities, for the year ended December 31, 2022
was $142.8 million, an increase of 13% compared to 2021. The increase in product
sales, which primarily include differentiated well completion products and
specialized laboratory instrumentation, was attributable to growth in both the
U.S. and international markets. Supply chain and logistical challenges continued
throughout 2022 which have caused some delays in delivery of our products to
certain international locations. Product sales revenue for the year ended
December 31, 2021 was $125.9 million, an increase of 14% compared to 2020.

Cost of Services, excluding depreciation



Cost of services for the year ended December 31, 2022 was $274.3 million, or an
increase of 2% compared to 2021, which corresponded with the change in revenue.
The restoration of substantially all employee compensation and benefit costs
during 2022 resulted in a higher employee compensation cost, however operating
expenses outside the U.S., and paid in local currencies, were lower when
translated into U.S. Dollars, as the U.S. Dollar strengthened against most
foreign currencies during 2022. Cost of services for the year ended December 31,
2021 was $267.6 million, or a decrease of 4% compared to 2020, corresponding to
the changes in revenue and the full benefit derived from the implementation of
various employee compensation and cost reduction initiatives that began after
April 2020. Cost of services expressed as a percentage of services revenue
increased to approximately 79% in 2022 primarily due to the effect of
restoration of employee compensation costs as discussed above. Cost of services
expressed as a percentage of service revenue increased to approximately 78% in
2021 from 74% in 2020, due to the subsequent restoration of certain cost
reduction initiatives in the second half of 2021, and how our fixed cost
structure is absorbed by revenue.

Cost of Product Sales, excluding depreciation



Cost of product sales for the year ended December 31, 2022 was $119.4 million,
increased 19% compared to 2021, which increased slightly higher than the change
in revenue. The restoration of substantially all employee compensation and
benefit costs during 2022 resulted in a higher employee compensation costs as
discussed above. In addition, inflation and global supply chain challenges
impacted our raw materials and shipping costs also resulted in increased costs
of product sales. Cost of product sales for the year ended December 31, 2021 was
$100.3 million, increased 5% compared to 2020, corresponding to the changes in
revenue, offset by improved manufacturing productivity and the full year benefit
derived from the implementation of various employee compensation and cost
reduction initiatives that began after April 2020. Cost of product sales
expressed as a percentage of product sales revenue increased to approximately
84% in 2022 as a result of elevated inflation and increased employee
compensation as discussed above. Cost of product sales expressed as a percentage
of product sales revenue decreased to 80% in 2021 from 86% in 2020 was primarily
due to improved manufacturing productivity and absorption of fixed costs on a
higher revenue base.

General and Administrative Expense, excluding depreciation



General and administrative ("G&A") expense includes corporate management and
centralized administrative services that benefit our operations. G&A expense was
$38.1 million in 2022, decreased 14% compared to 2021. The decrease is primarily
due to changes in compensation expense during the period and include accelerated
stock compensation expense recorded for retirement eligible employees of $3.9
million in 2022 compared to $7.2 million in 2021. Additionally, in 2022, $5.0
million of previously recognized compensation expense associated with
performance share awards was reversed, to align the compensation expense with
the vesting level of those performance share awards and revalue the awards.
However, the adjustments to reduce stock compensation expense in 2022 were
partially offset by the restoration of employee compensation and benefit costs
during 2022. G&A expenses were $44.2 million in 2021, an increase of
approximately $10.1 million, compared to 2020. The variance is primarily due to
changes in compensation expense during the period. In 2020, as a result of a
modification in the methodology of measuring performance conditions associated
with certain long-term employee stock-based compensation awards, these awards
were revalued, and $11.3 million of previously recognized stock compensation

                                       28
--------------------------------------------------------------------------------

expense was reversed in 2020. See Note 17 - Stock-Based Compensation of the Notes to the Consolidated Financial Statements for further details.

Depreciation and Amortization



Depreciation and amortization expense for the year ended December 31, 2022 was
$17.2 million decreased from $18.5 million and $20.9 million in 2021 and 2020,
respectively, as capital expenditures have also decreased over the same period
as a result of our cost reduction initiatives.

Impairments, Inventory Write-down and Other Charges



The geopolitical conflict between Russia and Ukraine, which began in February
2022 and continued through December 31, 2022, has resulted in disruptions to our
operations in Russia and Ukraine. The Company's operations and assets in Ukraine
are immaterial. As of December 31, 2022, all laboratory facilities, offices, and
locations in Russia continued to operate and remained profitable and no specific
asset losses were identified.

For the years ended December 31, 2022 and 2021, there were no triggering events
during the year, and, based on our assessment, we determined there was no
impairment for any of our reporting units or asset groups, which included
long-lived assets in Russia and Ukraine, and no impairment has been recorded in
2022 or 2021.

We completed our annual impairment assessment of goodwill for our reporting
units as of December 31, 2022 and 2021, by performing a qualitative assessment,
which indicated it was not more likely than not that there was an impairment and
therefore no quantitative test was required.

In 2020, the events associated with the COVID-19 pandemic and the resulting
sharp decrease in the consumption and demand for crude oil, which caused a sharp
decrease in the price of crude oil, was identified as a triggering event in
March 2020. In response to the triggering event, the Company updated its
analysis associated with future cash flows and the valuation of assets and
potential impairment of goodwill and intangible assets. Our updated analysis
resulted in the Company recording a total charge of $122.2 million for
impairment of goodwill and intangible assets in March 2020 in our Production
Enhancement operating segment. In addition, the Company recorded a charge of
$10.4 million associated with the devaluation and obsolescence of inventory,
primarily in our Production Enhancement operating segment. See Note 18 -
Impairments and Other Charges and Note 19 - Inventory Write-down of the Notes to
the Consolidated Financial Statements for further details.

Other (Income) Expense, net



The components of other (income) expense, net are as follows (in thousands):

                                                         For the Years Ended December 31,
                                                      2022              2021            2020
Gain on sale of assets                             $    (1,068 )     $      (427 )   $   (1,254 )
Results of non-consolidated subsidiaries                  (294 )             (62 )         (125 )
Foreign exchange (gain) loss, net                          229              (228 )        1,160
Rents and royalties                                       (709 )            (571 )         (466 )
Return on pension assets and other pension costs          (545 )            (306 )       (1,502 )
Gain on sale of business                                     -            (1,012 )            -
Insurance and other settlements                           (669 )          (2,236 )            -
Loss on lease abandonment                                    -                 -            504
Severance and other charges                              3,332                 -          3,943
Other, net                                                (998 )            (753 )         (434 )
Total other (income) expense, net                  $      (722 )     $    

(5,595 ) $ 1,826




In 2022, the Company sold its ownership interest of mineral rights in certain
properties for a net gain of $0.7 million which is included in gain on sale of
assets. We incurred property and other losses in a fire incident in 2020 that we
received full and final insurance settlement of $0.6 million in 2021. The North
America mid-continent winter storm in February 2021 caused business
interruptions and property losses to certain facilities, and we received
insurance settlements of $0.7 million and $1.6 million in 2022 and 2021,
respectively.

                                       29
--------------------------------------------------------------------------------


Foreign exchange (gain) loss, net is summarized in the following table (in
thousands):

                                        For the Years Ended December 31,
                                       2022             2021           2020
British Pound                       $      212       $       86       $   653
Canadian Dollar                            238               77           590
Colombian Peso                            (430 )           (281 )        (331 )
Euro                                      (382 )           (450 )         458
Indonesian rupiah                          379              123           (96 )
Other currencies, net                      212              217         

(114 ) Foreign exchange (gain) loss, net $ 229 $ (228 ) $ 1,160




Interest Expense

Interest expense for the year ended December 31, 2022 was $11.6 million compared
to $9.2 million in 2021. Interest expense in 2021, was lower by $1.4 million,
associated with a net gain recognized upon the settlement and restructuring of
our interest rate swap agreements, as described in Note 15 - Derivative
Instruments and Hedging Activities of the Notes to the Consolidated Financial
Statements. In 2022, the Company reduced its average outstanding debt by
approximately 12%, when compared to 2021, however the decrease in debt
outstanding was offset by a substantial increase in interest rates. Interest
expense for the year ended December 31, 2021 was $9.2 million compared to $14.4
million in 2020. Interest expense in 2021 was lower than 2020 due to the
following: 1) 2021 interest expense includes a $1.4 million net gain recorded
for the settlement and restructuring of our interest rate swap agreements as
discussed above, 2) the outstanding balance of our aggregated variable rate debt
was reduced by $56.0 million, and 3) the balance of our long-term fixed rate
debt was reduced by $15.0 million. See Note 11 - Long-term Debt, net of the
Notes to the Consolidated Financial Statements for further detail.

Income Tax Expense



Income tax expense was $10.3 million in 2022 and resulted in an effective tax
rate of 34.4%. The 2022 tax expense was primarily impacted by taxable gains in
local jurisdictions associated with foreign currency revaluation of U.S.
denominated receivables, primarily in the U.K. and Turkey as well as certain
non-deductible stock compensation expense in the United States. Income tax
expense was $15.9 million in 2021 and resulted in an effective tax rate of
44.0%. The 2021 tax expense was primarily impacted by taxable gains in local
jurisdictions associated with foreign currency revaluation of U.S. dollar
denominated receivables, primarily in Turkey, and certain non-deductible stock
compensation expense in the United States. The financial results for 2020
include a goodwill impairment of $114.0 million and resulted in a loss before
income taxes. However, the goodwill impairment was mostly non-deductible for
income tax purposes, and as a result income tax expense was $5.9 million in
2020.

See Note 10 - Income Taxes of the Notes to the Consolidated Financial Statements for further detail of income tax expense.


                                       30
--------------------------------------------------------------------------------

Segment Analysis

The following charts and tables summarize the annual revenue and operating results as a percentage of applicable revenue for our two complementary operating segments.


                                Segment Revenue

[[Image Removed: img195230833_5.jpg]][[Image Removed: img195230833_6.jpg]][[Image Removed: img195230833_7.jpg]]




                                                                                                 2022 / 2021        2021 / 2020
                            2022                    2021                     2020                           % Change
REVENUE:
Reservoir
Description          $ 307,691      62.8 %   $ 313,609      66.7 %   $  355,041       72.9 %             (1.9 )%           (11.7 )%
Production
Enhancement            182,044      37.2 %     156,643      33.3 %      132,226       27.1 %             16.2 %             18.5 %

Total revenue $ 489,735 100.0 % $ 470,252 100.0 % $ 487,267 100.0 %

              4.1 %             (3.5 )%
OPERATING INCOME
(LOSS):
Reservoir
Description*         $  22,902       7.4 %   $  28,958       9.2 %   $   55,044       15.5 %            (20.9 )%           (47.4 )%

Production


Enhancement*            16,351       9.0 %      15,163       9.7 %     (133,449 )   (100.9 )%             7.8 %               NM
Corporate and
other (1)                2,271       0.5 %       1,141       0.2 %        1,600        0.3 %               NM                 NM
OPERATING INCOME
(LOSS)               $  41,524       8.5 %   $  45,262       9.6 %   $  (76,805 )    (15.8 )%            (8.3 )%              NM


* Percentage, which represents operating margin, is based on operating income
(loss) divided by applicable revenue rather than total revenue.
'"NM" means not meaningful.
(1) "Corporate and other" represents those items that are not directly relating
to a particular operating segment.

Reservoir Description



Reservoir Description's operations are heavily exposed to international and
offshore project activity levels, with approximately 80% of its revenue sourced
from producing fields, development projects and movement of crude oil products
outside the U.S. The Company continues to see improvement in international
projects across several international regions; however, increases in project
activity were offset by disruptions caused by the Russia-Ukraine geopolitical
conflict, the COVID-19 pandemic and the devaluation of most currencies against
the U.S. Dollar, primarily the Euro and British Pound, in 2022 as previously
discussed.

Revenue from the Reservoir Description operating segment was $307.7 million in
2022 and down slightly when compared to $313.6 million in 2021 primarily due to
the factors discussed above. Revenue from the Reservoir Description operating
segment in 2021 of $313.6 million compared to $355.0 million in 2020, decreased
approximately 12% primarily due to the impact of the COVID-19 pandemic, which
began March 2020 and continued throughout 2021. The COVID-19 pandemic resulted
in reduced activity associated with the exploration and production of oil and
gas, as well as delays and disruptions to project workflows that slowed the
progress on long term international and offshore projects. In addition, various
weather events, such as the North America mid-continent winter storm and major
named storms in the Gulf of Mexico caused a significant disruption to crude oil
production and supply activities during 2021.

                                       31
--------------------------------------------------------------------------------


We continue to focus on large-scale core analysis and reservoir fluids
characterization studies in the Asia-Pacific region, offshore Europe and Africa,
offshore South America, North America, and the Middle East. We are also engaged
on both newly developed fields and brownfield extensions in offshore areas such
as Australia, Brazil, Guyana, the Gulf of Mexico, the Middle East and the North
Sea. Analysis of crude oil derived products also occurs in every major producing
region of the world. In particular, we anticipate increased demand for our
proprietary laboratory technological services in the Middle East as a result of
several factors, including Core Lab's completion of a comprehensive reservoir
fluid laboratory in Doha, Qatar, resumption of production from the Wafra
oilfield located within the onshore Partitioned Neutral Zone in the southern
part of Kuwait, as well as expansion of the North Gas Field in Qatar.
Additionally, in 2022, Core Lab, under the direction of The CarbonNet Project
commenced the second phase of advanced rock property analysis of conventional
core extracted from the Gular-1 appraisal well, which is associated with the
assessment of a large prospective geologic subsurface structure located in the
Gippsland Basin offshore the southeast coast of Australia which could be used
for carbon capture and sequestration.

Operating income of $22.9 million in 2022 decreased from $29.0 million in 2021.
Operating margins decreased to 7.4% in 2022 compared to 9.2% in 2021. The
decrease in operating income and operating margin in 2022, correlates to the
decrease in revenue and the decrease in operating margins reflect the increase
in costs during 2022, associated with the Company restoring employee
compensation costs and benefits. Operating income of $29.0 million in 2021
significantly decreased compared to $55.0 million in 2020. Operating margins
decreased to 9.2% in 2021 compared to 15.5% in 2020. The decrease in operating
income and operating margin in 2021 correlates to the decrease in revenue and
reflects additional costs associated with disruptions and damage to facilities
caused by weather events during 2021 as discussed above. In addition, 2020
includes and adjustment of $7.6 million to reverse previously recognized stock
compensation expense for certain employees' performance share awards. See Note
17 - Stock-Based Compensation of the Notes to the Consolidated Financial
Statements for further detail.

Production Enhancement



Production Enhancement's operations are largely focused on complex completions
in unconventional, tight-oil reservoirs in the U.S. as well as conventional
projects across the globe. Drilling and completion activity levels in the U.S.
onshore market began to significantly decrease starting in March of 2020 due to
the global pandemic and bottomed out at a historically low level in May of 2020.
Activity levels in the U.S. onshore market began to recover in the second half
of 2020, and activity levels for both the U.S. onshore and international markets
continued to strengthen in 2021 and 2022. However, the pace of growth in the
U.S. onshore market was slower in 2022 compared to 2021.

Revenue from the Production Enhancement operating segment of $182.0 million in
2022 increased 16% compared to 2021. The increase was driven by both an increase
in the drilling and completion of onshore wells in the U.S. and improved
activity in international markets. International sales continue to be impacted
by the challenges in the global supply chains and logistical challenges that
caused delays in delivery of our products to certain international locations.
Revenue from the Production Enhancement operating segment of $156.6 million in
2021 increased approximately 19% compared to 2020 primarily driven by a
significant increase in the drilling and completion of wells in the U.S. onshore
market. The U.S. average onshore rig count increased approximately 53% in 2022
and 10% in 2021 compared to 2021 and 2020, respectively.

Operating income of $16.4 million in 2022 compared to $15.2 million in 2021. The
increase in operating income correlates to the increase in revenue, however,
operating costs in 2022 increased due to the restoration of employee
compensation and benefit costs and the inflationary impact on our raw materials
and shipping costs. Operating margin of 9.0% in 2022 decreased from 9.7% in 2021
primarily due to the increase in costs as discussed above. Operating income of
$15.2 million in 2021 compared to an operating loss of $133.4 million in 2020.
In 2020, we recorded non-cash charges of $132.6 million for impairment of
goodwill, intangible assets and inventory write-down and other charges. See Note
18 - Impairments and Other Charges and Note 19 - Inventory Write-down of the
Notes to the Consolidated Financial Statements for further details. This was
partially offset by the benefit of cost reduction initiatives implemented during
2020 and reversal of previously recognized stock compensation expense associated
with certain employees' long-term stock-based performance awards of $3.6
million. Operating income (loss) in 2020, after excluding these net non-cash
charges was a loss of $0.8 million. The increase in operating income in 2021
compared to 2020, correlates to the increase in revenue. Operating margin was
9.7% in 2021, compared to a negative margin of 100.9% in 2020. The increased
operating margin in 2021 compared to 2020 was primarily driven by the effect of
non-cash charges recorded in 2020, as well as improved operating efficiencies
associated with increased activity levels in 2021, as discussed above. The
operating margin for 2020 was breakeven, when excluding the non-cash charges
associated with the goodwill impairment, intangible assets and inventory write
down.

Liquidity and Capital Resources


                                       32
--------------------------------------------------------------------------------

General



We have historically financed our activities through cash on hand, cash flows
from operations, bank credit facilities, equity financing and the issuance of
debt. Cash flows from operating activities provide the primary source of funds
to finance operating needs, capital expenditures and our dividend and share
repurchase programs. We believe our future cash flows from operations,
supplemented by our borrowing capacity under our Amended Credit Facility and the
ability to issue additional equity and debt, should be sufficient to fund our
debt requirements, capital expenditures, working capital, dividend payments and
future acquisitions. The Company will continue to monitor and evaluate the
availability of debt and equity markets.

In response to market conditions, Core Lab's Supervisory Board approved a plan
to reduce the Company's quarterly dividends to $0.01 per share beginning with
the second quarter of 2020 and to focus excess free cash flow on debt reduction.
In 2020, the Company implemented cost reduction initiatives, which included: (i)
corporate and operating cost reductions; (ii) reduction in annual capital
expenditures, and (iii) eliminating all non-essential costs. The corporate and
operating cost reductions included reductions in workforce and reduction of
senior executive and employee compensation. These initiatives continued in 2021.

Following increased activity levels during the second half of 2021, the Company
progressively reinstated certain employee costs, and in January 2022, employee
salaries were fully reinstated. Certain employee benefit plans have been
partially reinstated beginning April 2022, and the Company will continue to
evaluate the reinstatement of those benefits in 2023. Additionally, the Company
has maintained its reduced dividend plan that was approved and implemented from
second quarter of 2020, and excess free cash flow continues to primarily be used
towards reducing debt.

On July 25, 2022, we, along with our wholly owned subsidiary Core Laboratories
(U.S.) Interests Holdings, Inc. entered into an Eighth Amended and Restated
Credit Agreement (as amended, the "Amended Credit Facility") modifying and
extending the existing credit facility for an aggregate borrowing commitment of
$135 million with a $50 million "accordion" feature. The Amended Credit Facility
provided, among other things, a temporary increase to the maximum leverage ratio
permitted under the Amended Credit Facility through September 30, 2022. See Note
11 - Long-term Debt, net of the Notes to the Consolidated Financial Statements
for additional information.

On December 17, 2020, we entered into an Equity Distribution Agreement with
Wells Fargo Securities, LLC for the issuance and sale of up to $60.0 million of
our common shares. Under terms of the Equity Distribution Agreement, sales of
our common shares could be made by any method deemed to be an "at-the-market
offering" as defined in Rule 415 under the Securities Act of 1933, as amended
(the "2020 ATM program"). In March 2021, we completed the sale of 1,658,012
common shares under the agreement at an average price of $36.19 per share, which
generated aggregate proceeds of $59.1 million, net of commission and other
associated costs. Proceeds were used to reduce debt on the Company's credit
facility in 2021.

On June 9, 2022, we entered into an Equity Distribution Agreement with certain
banks (the "2022 Equity Distribution Agreement") for the issuance and sale of up
to $60.0 million of our common shares. Under the terms of the 2022 Equity
Distribution Agreement, sales of our common shares may be made by any method
deemed to be an "at-the-market offering" as defined in Rule 415 under the
Securities Act of 1933 (the "2022 ATM program"). For the year ended December 31,
2022 and through February 9, 2023, the Company has not sold any shares under the
2022 Equity Distribution Agreement. See Note 14 - Equity of the Notes to the
Consolidated Financial Statements for additional information.

On January 12, 2021, the Company issued the 2021 Senior Notes with aggregate
principal amount of $60 million in a private placement. The net proceeds from
the 2021 Senior Notes were used exclusively to reduce outstanding debt under the
Company's Credit Facility, which increased the available borrowing capacity and
liquidity for the Company. See Note 11 - Long-term Debt, net of the Notes to the
Consolidated Financial Statements for additional information.

On September 30, 2021, the Company retired $75 million in Series A of the 2011
Senior Notes. Series A of the 2011 Senior Notes were retired using a combination
of cash on hand and $55 million in proceeds drawn from our Credit Facility. We
intend to maintain sufficient borrowing capacity under the Credit Facility to
both retire maturing debt obligations and provide additional liquidity, should
the company require it for other purposes.

As we are a Netherlands holding company, we conduct substantially all of our
operations through subsidiaries. Our cash availability is largely dependent upon
the ability of our subsidiaries to pay cash dividends or otherwise distribute or
advance funds to us and on the terms and conditions of our existing and future
credit arrangements. There are no restrictions preventing any of our
subsidiaries from repatriating earnings, and there are no restrictions or income
taxes associated with distributing cash to the parent company through loans or
advances. As of December 31, 2022, $9.4 million of our $15.4 million of cash was
held by our foreign subsidiaries, including the U.S.

                                       33
--------------------------------------------------------------------------------

Cash Flows

The following table summarizes cash flows (in thousands):



                                              For the Years Ended December 31,
                                             2022             2021          2020
Cash provided by (used in):
Operating activities                      $    24,956       $  36,579     $  57,868
Investing activities                           (3,856 )       (10,223 )       7,851
Financing activities                          (23,375 )       (22,459 )     (63,005 )
Net change in cash and cash equivalents   $    (2,275 )     $   3,897     $ 

2,714




Cash provided by operating activities in 2022, decreased approximately $11.6
million compared to 2021 due to a small decrease net income in 2022 compared to
2021, however, cash operating expenses and cash taxes paid increased in 2022,
and these cash operating expenses and cash taxes paid were offset by a
significant reduction in non-cash stock compensation expense during 2022.The
increase in cash operating expenses during 2022 is primarily related to
inflation and restoration of employee benefits in 2022. Cash provided by
operating activities in 2021, decreased $21.3 million primarily due to increased
working capital requirements of $21.0 million as market conditions and activity
levels improved in the second half of 2021.

Cash used by investing activities was $3.9 million in 2022 compared to $10.2
million in 2021. The decrease was primarily due to lower capital expenditure of
$3.3 million and higher proceeds from sale of assets and net proceeds from
company-owned life insurance policies of $1.2 million and $2.3 million,
respectively, in 2022. Cash used by investing activities was $10.2 million in
2021 compared to cash provided by investing activities of $7.9 million in 2020.
The variance was primarily due to higher capital expenditures of $13.5 million
in 2021 compared to $11.9 million in 2020 and additional distribution received
from company-owned life insurance policies of $20.4 million in 2020, partially
offset by total proceeds of approximately $1.6 million from sale of business and
insurance recovery in 2021.

Cash used in financing activities in 2022 of $23.4 million compared to $22.5
million in 2021, increased $0.9 million primarily due to higher debt issuance
costs in 2022 associated with renewing the Amended Credit Facility in 2022 as
discussed above. Cash used in financing activities in 2021 decreased $40.5
million compared to 2020 as a result of: 1) a reduction of $10.6 million in
dividends paid, and 2) net proceeds of $59.1 million raised in 2021 by issuing
common shares through the 2020 ATM program. These decreases in cash used were
offset by 1) $71.0 million of net reduction in long-term debt during 2021
compared to $46.0 million in 2020, and 2) the repurchase of our common shares of
$8.3 million in 2021 compared to $2.8 million in 2020.

During 2022, we repurchased 174,348 shares of our common stock for an aggregate
amount of $3.9 million, or an average price of $22.39 per share, including
rights to 102,067 shares valued at $2.1 million surrendered to us pursuant to
the terms of a stock-based compensation plan in consideration of the
participants' tax burdens resulting from the issuance of common shares under
that plan. See Note 14 - Equity of the Notes to the Consolidated Financial
Statements for additional information. We believe our share repurchase program
has been beneficial to our shareholders over the longer term. Our share price
has increased from $4.03 per share in 2002, when we began to repurchase shares,
to $20.27 per share on December 31, 2022, an increase exceeding 400%.

We utilize the non-GAAP financial measure of free cash flow to evaluate our cash
flows and results of operations. Free cash flow is defined as net cash provided
by operating activities (which is the most directly comparable U.S. GAAP
measure) less cash paid for capital expenditures. Management believes that free
cash flow provides useful information to investors regarding the cash that was
available in the period that was in excess of our needs to fund our capital
expenditures and operating activities. Free cash flow is not a measure of
operating performance under U.S. GAAP, and should not be considered in isolation
nor construed as an alternative to operating profit, net income (loss) or cash
flows from operating, investing or financing activities, each as determined in
accordance with U.S. GAAP. Free cash flow does not represent residual cash
available for distribution because we may have other non-discretionary
expenditures that are not deducted from the measure. Moreover, since free cash
flow is not a measure determined in accordance with U.S. GAAP and thus is
susceptible to varying interpretations and calculations, free cash flow, as
presented, may not be comparable to similarly titled measures presented by other
companies. The following table reconciles this non-GAAP financial measure to the
most directly comparable measure calculated and presented in accordance with
U.S. GAAP (in thousands):

                                       34
--------------------------------------------------------------------------------

                                                For the Years Ended December 31,
Free Cash Flow Calculation                     2022             2021        

2020

Net cash provided by operating activities $ 24,956 $ 36,579 $ 57,868 Less: cash paid for capital expenditures (10,216 ) (13,539 )


  (11,880 )
Free cash flow                              $    14,740       $  23,040     $  45,988


The decrease in free cash flow in 2022 compared to 2021 was primarily due to
decreased cash provided by operating activities as discussed above, partially
offset by a decrease of $3.3 million in capital spending in 2022 The decrease in
free cash flow in 2021 compared to 2020 was primarily due to decreased cash
provided by operating activities as discussed above, additionally, increased
capital spending of $1.6 million in 2021, which were elevated by facility repair
costs for damages caused by the 2021 winter storm in North America.

Senior Notes, Credit Facility and Available Future Liquidity



We have three series of senior notes outstanding with an aggregate principal
amount of $135 million that were issued through private placement transactions.
Series B of the senior notes issued in 2011 ("2011 Senior Notes") consists of
$75 million in aggregate principal amount and bears interest at a fixed rate of
4.11% and is due in full on September 30, 2023. Interest on Series B of the 2011
Senior Notes is payable semi-annually on March 30 and September 30. We intend to
repay the 2011 Senior Notes Series B with borrowings under our existing
long-term Amended Credit Facility; therefore, we continue to classify them as
long-term debt.

Series A and Series B of the 2021 Senior Notes were issued and funded on January
12, 2021 (the "2021 Senior Notes" and together with the 2011 Senior Notes, the
"Senior Notes"). Series A of the 2021 Senior Notes consists of $45 million in
aggregate principal amount that bear interest at a fixed rate of 4.09% and is
due in full on January 12, 2026. Series B of the 2021 Senior Notes consists of
$15 million in aggregate principal amount that bears interest at a fixed rate of
4.38% and is due in full on January 12, 2028. Interest on each series of the
2021 Senior Notes is payable semi-annually on June 30 and December 30.

On July 25, 2022, we, along with our wholly owned subsidiary Core Laboratories
(U.S.) Interests Holdings, Inc. ("CLIH") entered into an Eighth Amended and
Restated Credit Agreement (as amended, the "Amended Credit Facility") modifying
and extending the existing credit facility for an aggregate borrowing commitment
of $135 million with a $50 million "accordion" feature. The Amended Credit
Facility is secured by first priority interests in (1) substantially all of the
tangible and intangible personal property, and equity interest of CLIH and
certain of the Company's U.S. and foreign subsidiary companies; and (2)
instruments evidencing intercompany indebtedness owing to the Company, CLIH and
certain of the Company's U.S. and foreign subsidiary companies. Under the
Amended Credit Facility, the Secured Overnight Financing Rate ("SOFR") plus
2.00% to SOFR plus 3.00% will be applied to outstanding borrowings. Any
outstanding balance under the Amended Credit Facility is due at maturity on July
25, 2026, subject to springing maturity on July 12, 2025, if the Company's
liquidity does not equal or exceed the principal amount of the 2021 Senior Notes
Series A outstanding on such date. The available capacity at any point in time
is reduced by outstanding borrowings and outstanding letters of credit which
totaled approximately $9 million at December 31, 2022, resulting in an available
borrowing capacity under the Amended Credit Facility of approximately $86
million. In addition to indebtedness under the Amended Credit Facility, we had
approximately $6 million of outstanding letters of credit and performance
guarantees and bonds from other sources as of December 31, 2022. The Amended
Credit Facility does not substantially alter the calculation of the net leverage
or interest coverage ratios. Pursuant to the terms of the Amended Credit
Facility, the maximum leverage ratio permitted is as follows:

           Quarter ending               Maximum leverage ratio permitted
June 30, 2022 and September 30, 2022                                 2.75
  December 31, 2022 and thereafter                                   2.50


The terms of the Amended Credit Facility and Senior Notes require us to meet
certain covenants, including, but not limited to, an interest coverage ratio
(calculated as consolidated EBITDA divided by interest expense) and a leverage
ratio (calculated as consolidated net indebtedness divided by consolidated
EBITDA), where consolidated EBITDA (as defined in each agreement) and interest
expense are calculated using the most recent four fiscal quarters. The Amended
Credit Facility and Senior Notes include a cross-default provision, whereby a
default under one agreement may trigger a default in the other agreements. The
Amended Credit Facility has more restrictive covenants with a minimum interest
coverage ratio of 3.00 to 1.00 and permits a maximum leverage ratio as described
above. The Amended Credit Facility allows non-cash charges such as impairment of
assets, stock compensation and other non-cash charges to be added back in the
calculation of consolidated EBITDA. The terms of our Amended Credit Facility
also allow us to negotiate in good faith to amend any ratio or requirement

                                       35
--------------------------------------------------------------------------------


to preserve the original intent of the agreement if any change in accounting
principles would affect the computation of any financial ratio or covenant of
the Amended Credit Facility. In accordance with the terms of the Amended Credit
Facility, our leverage ratio is 2.29, and our interest coverage ratio is 6.03,
each for the year ended December 31, 2022. We believe that we are in compliance
with all covenants contained in our Amended Credit Facility and Senior Notes.
Certain of our material, wholly-owned subsidiaries, are guarantors or
co-borrowers under the Amended Credit Facility and Senior Notes.

In March 2021, we entered into a new forward interest rate swap agreement for a
notional amount of $60 million and carried the fair value of the terminated 2014
and 2020 Variable-to-Fixed Swaps into the new agreement in a "blend and extend"
structured transaction. The purpose of this forward interest rate swap agreement
is to fix the underlying risk-free rate, that would be associated with the
anticipated issuance of new long-term debt by the Company in future periods. On
April 8, 2022, the forward interest rate swap agreement was terminated and
settled for a net gain of $0.6 million which is included in accumulated other
comprehensive income (loss). See Note 15 - Derivative Instruments and Hedging
Activities for additional information.

In addition to our repayment commitments under our Amended Credit facility and
our Senior Notes, we have non-cancellable operating lease arrangements under
which we lease office and lab space, machinery, equipment and vehicles. We also
have employer contribution commitments related to our Dutch pension plan with
amounts payable in the future based upon workforce factors that cannot be
estimated beyond one year. These material future contractual obligations are
discussed in Note 7 - Leases, Note 11 - Long-term Debt, net and Note 12 -
Pension and Other Postretirement Benefit Plans of the Notes to the Consolidated
Financial Statements.

We have no significant purchase commitments or similar obligations outstanding
at December 31, 2022. We also have uncertain tax positions of $3.5 million that
we have accrued for at December 31, 2022; the amounts and timing of payment, if
any, are uncertain. See Note 10 - Income Taxes of the Notes to the Consolidated
Financial Statements for further detail of this amount.

At December 31, 2022, we had tax net operating loss carry-forwards in various
jurisdictions of $55.6 million. Although we cannot be certain that these net
operating loss carry-forwards will be utilized, we anticipate that we will have
sufficient taxable income in future years to allow us to fully utilize the
carry-forwards that are not subject to a valuation allowance as of December 31,
2022. If unused, those carry-forwards which are subject to expiration may expire
during the years 2023 through 2036. During 2022, no material net operating loss
carry-forwards, which carried a full valuation allowance, expired unused.

We expect our investment in capital expenditures to track with client demand for
our services and products. Given the uncertain trend in industry activity
levels, we have not determined, at this time, the level of investment that will
be made in 2022. We will, however, continue to invest in the purchase or
replacement of obsolete or worn-out instrumentation, tools and equipment, to
consolidate certain facilities to gain operational efficiencies, and to increase
our presence where requested by our clients.

Outlook



The events associated with the COVID-19 pandemic that began in 2020 continued in
2021 and 2022. Certain international countries continued mandated shut-downs,
home sheltering and social distancing policies that initially caused uncertainty
in the demand for crude oil and associated products; however demand for these
products has recovered more quickly than global production causing crude-oil
commodity prices to increase significantly. Although U.S. onshore drilling and
completion activities improved during 2021 and strengthened in 2022, activity
still remains well below pre-pandemic levels. Additionally, international
activity continued to be adversely impacted by increasing infection rates
associated with new variant strains of the COVID-19 virus during 2021 and 2022,
which has continued to cause business disruptions associated with government
mandated shut-downs, travel restrictions, quarantine protocols and worksite
closures in various international regions. These disruptions started to ease
during the second half of 2022.

The geopolitical conflict between Russia and Ukraine that erupted in February
2022, has also resulted in disruptions to traditional supply chains associated
with the movement of crude oil, primarily impacting crude oil sourced from
Russia and imported into various European ports. However, the supply chains
associated with the movement of crude oil continue realigning to new logistical
patterns, as we expect Europe will find new suppliers of crude oil to import
into the region. These events have caused energy prices to increase throughout
the world but even more so in Europe, as the current global demand for crude oil
and natural gas has remained at a high level. Core Lab expects supply lines to
realign, and the Company's volume of associated laboratory services to increase
commensurate with the trading and movement of crude-oil into Europe and across
the globe. Additionally, European countries have begun elevating the level of
LNG imports to offset the loss of natural gas sourced from Russia. The Company
provides some laboratory analytical services associated with the movement of LNG
products, which may offer some additional opportunities for the Company in this
region. In March 2022, completion product

                                       36
--------------------------------------------------------------------------------

sales delivered through our Production Enhancement operating segment into Ukraine were temporarily suspended and continue to be impacted by disruptions in freight transport services.



The situation continues to evolve and the United States, the European Union, the
United Kingdom and other countries may implement additional sanctions, export
controls or other measures against Russia, Belarus and other countries, regions,
officials, individuals or industries in the respective territories. We have no
way to predict the progress or outcome of the conflict in Ukraine or its impacts
in Ukraine, Russia or Belarus as the conflict, and any resulting government
responses, are fluid and beyond our control.

Crude-oil commodity prices remain volatile and increased significantly
throughout most of 2022. It is anticipated that crude-oil commodity prices for
the near-to-mid-term will remain elevated and supported by increasing demand
with only moderate growth in production levels. As such, activities associated
with the production of oil and gas continued to increase in 2022, are expected
to continue increasing moderately in 2023. The oil and gas industry continues to
face limitations in personnel, equipment, and supply chain disruptions, which
may moderate future growth, as well as the allocation of capital resources by
oil and gas producing companies. Our clients' activities associated with the
energy markets are also expected to increase in 2023, but may be impacted by the
outlook for the global economy, decisions by OPEC nations associated with the
production and supply of crude oil to the market, the pace of China's recovery
from the COVID-19, and considerations associated with the Russia-Ukraine
geopolitical conflict.

Our major clients continue to focus on capital management, return on invested
capital ("ROIC"), free cash flow, and returning capital to their shareholders,
as opposed to a focus on production growth. The companies adopting value versus
volume metrics tend to be the more technologically sophisticated operators and
form the foundation of Core Lab's worldwide client base. As oil and gas
commodity prices are expected to remain elevated in the near to mid-term, the
Company expects our clients' activities associated with increasing oil and gas
reserves and production levels will continue to increase in the coming years.
Additionally, some of our major clients have begun investing and developing
other sources of energy, including renewables, and focusing on emission
reduction initiatives. Some of these initiatives include deployment of
technologies associated with hydrogen or lithium-based batteries, and carbon
capturing and sequestration. Considering a longer-term strategy, we expect to be
well positioned as our clients continue their focus on employing higher
technological solutions in their efforts to optimize production and estimated
ultimate recovery in the most cost efficient and environmentally responsible
manner.

We believe oil and gas operators will continue to manage their capital spending
within free cash flow and maintain their focus on improving and maintaining a
stronger balance sheet, which could constrain future growth in activities
associated with the production of oil and gas.

Core Laboratories expects that 2023 capital and operating budgets of oil and gas
operators will expand over 2022 levels but also include a higher allocation of
capital towards energy transition activities. Some of our major clients have
begun actively investing and developing other renewable sources of energy and
focusing on emission reduction initiatives. Core Laboratories is participating
in some of these initiatives, which include deployment of technologies and new
projects associated with hydrogen or lithium-based batteries, and CCS. In 2022,
there has been moderate improvement in international activity levels, as the
international rig count increased to 1,055 as we exited the year and is up
approximately 7% from the end of 2021. We continue to work with clients and
discuss the progression of longer-term international projects. Additionally, the
reservoir fluids analysis performed on projects associated with current
producing fields continues to be critical and has been less affected by lower
commodity prices for crude oil.

As part of our long-term growth strategy, we continue to expand our market
presence by opening or expanding facilities in strategic areas and realizing
synergies within our business lines consistent with client demand and market
conditions. More recently, we have expanded our laboratory capabilities in
Qatar, Saudi Arabia and Brazil. We believe our market presence in strategic
areas provides us a unique opportunity to serve our clients who have global
operations, whether they are international oil companies, national oil
companies, or independent oil companies.

Core Lab believes continued assessment of market conditions, will allow Core
Lab, as it has for over 85 years, to navigate through these challenging times.
Core Lab remains focused on preserving the quality of service for its clients
and producing returns for its shareholders.

Critical Accounting Estimates



The preparation of financial statements in accordance with U.S. GAAP requires us
to make certain estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of assets and liabilities at the date of
the financial statements and the reported amounts of revenue and expenses during
the reporting period. We evaluate our estimates on an

                                       37
--------------------------------------------------------------------------------


ongoing basis and determine the adequacy of our estimates based on our
historical experience and various other assumptions that we believe are
reasonable under the circumstances. By nature, these judgments are subject to an
inherent degree of uncertainty. We consider an accounting estimate to be
critical if it is highly subjective and if changes in the estimate under
different assumptions would result in a material impact on our financial
condition and results of operations. The following transaction types require
significant judgment and, therefore, are considered critical accounting policies
as of December 31, 2022.

Income Taxes

Our income tax expense includes income taxes of the Netherlands, the U.S. and
other foreign countries as well as local, state and provincial income taxes. We
recognize deferred tax assets or liabilities for the differences between the
financial statement carrying amount and tax basis of assets and liabilities
using enacted tax rates in effect for the years in which the asset is expected
to be recovered or the liability is expected to be settled. We estimate the
likelihood of the recoverability of our deferred tax assets (particularly, net
operating loss carry-forwards). Any valuation allowance recorded is based on
estimates and assumptions of taxable income into the future and a determination
is made of the magnitude of deferred tax assets which are more likely than not
to be realized. Valuation allowances of our net deferred tax assets aggregated
to $9.3 million and $7.4 million at December 31, 2022 and 2021, respectively. If
these estimates and related assumptions change in the future, we may be required
to record additional valuation allowance against our deferred tax assets and our
effective tax rate may increase which could result in a material adverse impact
on our financial position, results of operations and cash flows. We record a
liability for unrecognized tax benefits resulting from uncertain tax positions
taken or expected to be taken in our tax return. We also recognize interest and
penalties, if any, related to unrecognized tax benefits in income tax expense.

Long-Lived Assets, Intangibles and Goodwill



Property, plant and equipment are carried at cost less accumulated depreciation.
Major renewals and improvements are capitalized while maintenance and repair
costs are charged to expense as incurred. They are depreciated using the
straight-line method based on their individual estimated useful lives, except
for leasehold improvements, which are depreciated over the remaining lease term,
if shorter. We estimate the useful lives and salvage values of our assets based
on historical data of similar assets. When long-lived assets are sold or
retired, the remaining costs and related accumulated depreciation are removed
from the accounts and any resulting gain or loss is included in income. These
capitalized long-lived assets could become impaired if our operating plans or
business environment changes.

Intangible assets, including patents, trademarks and technology, are carried at
cost less accumulated amortization. Intangibles with determinable lives are
amortized using the straight-line method based on the estimated useful life of
the intangible. Intangibles with indeterminable lives, which consist primarily
of corporate trade names, are not amortized, but are tested for impairment
whenever events or changes in circumstances indicate that impairment is
possible.

We review our long-lived assets ("LLA"), including definite-lived intangible and
right-of-use assets, for impairment when events or changes in circumstances
indicate that their net book value may not be recovered over their remaining
service lives. Indicators of possible impairment may include significant
declines in activity levels in regions where specific assets or groups of assets
are located, extended periods of idle use, declining revenue or cash flow or
overall changes in general market conditions.

Whenever possible impairment is indicated, we compare the carrying value of the
assets or asset group to the sum of the estimated undiscounted future cash flows
expected from use, plus salvage value, less the costs of the subsequent
disposition of the assets. If impairment is still indicated, we compare the fair
value of the assets to the carrying amount and recognize an impairment loss for
the amount by which the carrying value exceeds the fair value.

We did not record impairment charges relating to our long-lived assets and
intangible assets during the years ended December 31, 2022 and 2021. We recorded
an impairment charge of $8.2 million for certain intangible assets during the
year ended December 31, 2020.

The geopolitical conflict between Russia and Ukraine, which began in February
2022 and has continued through December 31, 2022, has resulted in disruptions to
our operations in Russia and Ukraine. The Company evaluated LLA in Russia and
Ukraine as part of our assessment of our assets group and did not identify
triggering events as of December 31, 2022. The Company's operation, assets and
facilities in Ukraine are immaterial. As of December 31, 2022, all laboratory
facilities, offices, and locations in Russia continued to operate and remained
profitable and no specific asset losses were identified.

We record goodwill as the excess of the purchase price over the fair value of
the net assets acquired in acquisitions accounted for under the purchase method
of accounting. Goodwill is not subject to amortization and is tested for
impairment annually or

                                       38
--------------------------------------------------------------------------------


more frequently if events or changes in circumstances indicate goodwill is more
likely than not impaired. We assess goodwill for impairment either by performing
a qualitative assessment or a quantitative test. The qualitative assessment is
to determine whether the existence of events or circumstances leads to a
determination that it is more likely than not that the fair value of a reporting
unit is less than its carrying amount, including goodwill. If it is concluded
that it is more-likely-than not that an impairment exists, a quantitative test
is required which compares the estimated fair value of a reporting unit to its
carrying value. If the estimated fair value of a reporting unit is less than its
carrying value, then there is an impairment loss limited to the amount of
goodwill allocated to that reporting unit. Our reporting units are the same as
our two operating segments. Significant judgments and assumptions are inherent
in our estimate of future cash flows used to determine the estimate of the
reporting unit's fair value which include assumptions regarding future revenue
growth rates, discount rates and expected margins.

We completed our annual impairment assessment of goodwill for our reporting
units as of December 31, 2022 and 2021, by performing a qualitative assessment,
which indicated it was not more likely than not that there was an impairment and
therefore no quantitative test was required. We performed detailed quantitative
test and recorded an impairment charge of $114.0 million for goodwill of our
Production Enhancement reporting units during the year ended December 31, 2020.

Any subsequent impairment loss could result in a material adverse effect upon our financial position and results of operations.

Off-Balance Sheet Arrangements



We do not have any off-balance sheet financing arrangements such as
securitization agreements, liquidity trust vehicles or special purpose entities.
As such, we are not materially exposed to any financing, liquidity, market or
credit risk that could arise if we had engaged in such financing arrangements.

Forward-Looking Statements



This Form 10-K and the documents incorporated in this Form 10-K by reference
contain forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Exchange Act. These
"forward-looking statements" are based on an analysis of currently available
competitive, financial and economic data and our operating plans. They are
inherently uncertain and investors should recognize that events and actual
results could turn out to be significantly different from our expectations. By
way of illustration, when used in this document, words such as "anticipate",
"believe", "expect", "intend", "estimate", "project", "will", "should", "could",
"may", "predict" and similar expressions are intended to identify
forward-looking statements. You are cautioned that actual results could differ
materially from those anticipated in forward-looking statements. Any
forward-looking statements, including statements regarding the intent, belief or
current expectations of us or our management, are not guarantees of future
performance and involve risks, uncertainties and assumptions about us and the
industry in which we operate, including, among other things:

our ability to continue to develop or acquire new and useful technology;

the realization of anticipated synergies from acquired businesses and future acquisitions;

our dependence on one industry, oil and gas, and the impact of commodity prices on the expenditure levels of our clients;

competition in the markets we serve;


the risks and uncertainties attendant to adverse industry, political, economic
and financial market conditions, including stock prices, government regulations,
interest rates and credit availability;

unsettled political conditions, war, civil unrest, currency controls and governmental actions in the numerous countries in which we operate;

changes in the price of oil and natural gas;

major outbreak of global pandemic and restricting mobilization of field personnel;



•
weather and seasonal factors;

integration of acquired businesses; and

the effects of industry consolidation.



Our business depends, to a large degree, on the level of spending by oil and gas
companies for exploration, development and production activities. Therefore, a
sustained increase or decrease in the price of natural gas or oil, which could
have a material

                                       39
--------------------------------------------------------------------------------

impact on exploration, development and production activities, could also materially affect our financial position, results of operations and cash flows.



The above description of risks and uncertainties is by no means all-inclusive,
but is designed to highlight what we believe are important factors to consider.
For a more detailed description of risk factors, please see "Item 1A. Risk
Factors" in this Form 10-K and our reports and registration statements filed
from time to time with the SEC.

All forward-looking statements in this Form 10-K are based on information
available to us on the date of this Form 10-K. We do not intend to update or
revise any forward-looking statements that we may make in this Form 10-K or
other documents, reports, filings or press releases, whether as a result of new
information, future events or otherwise, unless required by law.

Recent Accounting Pronouncements

Pronouncements Adopted



In December 2019, the FASB issued ASU 2019-12 ("Simplifying the Accounting for
Income Taxes") which affects general principles within Topic 740, Income Taxes.
The amendment removes exceptions related to the incremental approach for
intraperiod tax allocation, the recognition of a deferred tax liability for
equity method investments in a foreign subsidiary, and the methodology for
calculating income taxes in an interim period. The standard also simplifies the
accounting for franchise taxes, transactions that result in a step-up in the tax
basis of goodwill, the effect of an enacted change in tax laws on the tax rate
computation in interim periods, and specifying that an entity is not required to
allocate consolidated tax expense to a legal entity not subject to tax in its
separate financial statements. This standard is effective for fiscal years, and
interim periods within those fiscal years, beginning after December 15, 2020. We
adopted this standard on January 1, 2021, and there has been no significant
impact on our consolidated financial statements or on our accounting policies
and processes.

In March 2020, the FASB issued ASU 2020-04 ("Facilitation of the Effects of
Reference Rate Reform on Financial Reporting") which provides temporary optional
guidance to ease the potential burden in accounting for reference rate reform.
The new guidance provides optional expedients and exceptions for applying
generally accepted accounting principles to contract modifications and hedging
relationships, subject to meeting certain criteria, that reference LIBOR or
another reference rate expected to be discontinued. The ASU is intended to help
stakeholders during the global market-wide reference rate transition period.
During the year ended December 31, 2022, we elected to apply the optional
expedient for hedging relationships affected by reference rate reform upon the
Company's amending its existing credit facility that included a change in the
reference rate. Accordingly, no outstanding balance on the Amended Credit
Facility will preclude cash flow hedging with existing hedging instruments. See
Note 11 - Long-term Debt, net and Note 15 - Derivative Instruments and Hedging
Activities.

© Edgar Online, source Glimpses